Khan, London
Afnan Khan, London GB
Patent application number | Description | Published |
---|---|---|
20150067330 | METHOD AND SYSTEM FOR NETWORK DATA ACCESS - Embodiments of the invention provide a method and system which allow for ready revocation of end user access rights by virtue of storing data in an encrypted form in a network environment, and using a trusted proxy server to re-encrypt the data itself to permit eventual decryption of the data by an authorised end user. However, if the end user's access rights are revoked then the trusted proxy does not perform the re-encryption of the data, and the end user is not then able to subsequently decrypt data stored in the network environment, even if it is able to access the data, without permission. Embodiments therefore have advantages that access control is decoupled from data confidentiality to provide scalability, and revocation of user access rights can be accomplished without requiring re-encryption of the stored data. | 03-05-2015 |
Afzal Khan, London GB
Patent application number | Description | Published |
---|---|---|
20090209755 | FUSED AMINODIHYDROTHIAZINE DERIVATIVES - A compound represented by the general formula: | 08-20-2009 |
20090215771 | JNK INHIBITORS - The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation. | 08-27-2009 |
20100035878 | INHIBITORS OF C-JUN N-TERMINAL KINASES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS RELATING TO APOPTOSIS AND/OR INFLAMMATION - The present invention provides novel compounds of formula I and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation. | 02-11-2010 |
20100069354 | 7-AZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE - The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof, the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and the use in medicine and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and/or and autoimmune diseases. The invention also provides processes for the manufacture of said compounds of formula (I) or a pharmaceutically acceptable salt thereof and compositions containing them. | 03-18-2010 |
20100069358 | USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE - The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and/or and autoimmune diseases. The invention also provides processes for the manufacture of said compounds of formula (I) or a pharmaceutically acceptable salt thereof and compositions containing them. | 03-18-2010 |
20100317850 | CONDENSED AMINODIHYDROTHIAZINE DERIVATIVE - Disclosed is a compound represented by General formula (I), a pharmaceutically acceptable salt thereof, or a solvate of the compound or the pharmaceutically acceptable salt, which has an inhibitory activity of the production of Aβ or a BACE1-inhibiting activity, and is therefore useful as a prophylactic or therapeutic agent for Aβ-induced neurodegenerative diseases typified by Alzheimer-type dementia. Wherein the ring A represents a C | 12-16-2010 |
20110152253 | SPIROAMINODIHYDROTHIAZINE DERIVATIVES - A compound represented by the general formula (I): or a pharmaceutically acceptable salt thereof, has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer-type dementia. | 06-23-2011 |
20120094984 | FUSED AMINODIHYDROTHIAZINE DERIVATIVES - A compound represented by the general formula: | 04-19-2012 |
20130203741 | FUSED AMINODIHYDROTHIAZINE DERIVATIVES - A compound represented by the general formula: | 08-08-2013 |
Faaizah Khan, London GB
Patent application number | Description | Published |
---|---|---|
20120232251 | GLUCOSE SENSOR - The invention relates to a glucose binding protein comprising amino acid mutations relative to the wild type sequence at the following positions: (i) H 152, (ii) A213; and (iii) L238 wherein the mutation at position H 152 is H152C. The invention further relates to such a glucose binding protein comprising the mutations H152C, A213R and L238S, in particular when linked to an environmentally sensitive dye such as badan. | 09-13-2012 |
Kabir Khan, London GB
Patent application number | Description | Published |
---|---|---|
20080301635 | Per-instance and per-class aspects - An object-oriented program development tool supports the specification and implementation program aspects. Cross-cutting concerns can be identified, and key points in a program augmented with arbitrary functionality. Classes and individual objects can be associated with different advices. Interceptors can be added dynamically on a per-instance and/or a per-class basis. | 12-04-2008 |
20080301636 | Per-instance and per-class aspects - An object-oriented program development tool supports the specification and implementation program aspects. Cross-cutting concerns can be identified, and key points in a program augmented with arbitrary functionality. Classes and individual objects can be associated with different advices. Interceptors can be added dynamically on a per-instance and/or a per-class basis. | 12-04-2008 |
Rizwan Khan, London GB
Patent application number | Description | Published |
---|---|---|
20150112643 | INFRA-RED ANALYSIS OF DIAMONDS - The invention provides a method of automating the classification of a diamond gemstone. An infra-red absorption spectrum of the gemstone is provided. Features corresponding to absorption by water and intrinsic absorption by a diamond lattice are subtracted from the absorption spectrum. The spectrum is analysed to identify predetermined absorption features corresponding to lattice defects in the diamond. The gemstone is classified according to the intensities of the predetermined absorption features. The results of the classification are saved in a database. | 04-23-2015 |
Rizwan Uddin Ahmad Khan, London GB
Patent application number | Description | Published |
---|---|---|
20110151226 | SYNTHETIC CVD DIAMOND - The present disclosure relates to methods for synthesizing synthetic CVD diamond material and high quality synthetic CVD diamond materials. | 06-23-2011 |
Sarfaraz Akhtar Khan, London GB
Patent application number | Description | Published |
---|---|---|
20100221468 | PRINTABLE OXYGEN SENSING COMPOSITION - An ink composition comprising an oxygen sensitive dye capable of fluorescing in a manner proportional to oxygen content; and a polymer matrix for the dye, the polymer matrix having units with pendant sulphonic acid or phosphonic acid groups or salts or esters of such groups, can be used with an appropriate meter to measure the oxygen content of packages in a non-invasive manner. | 09-02-2010 |
Sher Khan, London GB
Patent application number | Description | Published |
---|---|---|
20150278497 | BIOMETRIC DATA APPARATUS - The present disclosure provides a cover for an electronic device and a biometric data apparatus for communication with an electronic device, wherein the biometric data apparatus comprises: a body; and a biometric data input element formed on the body; wherein at least part of the body is configured such that the biometric data apparatus may be releasably coupled to the electronic device when the cover for the electronic device is fitted to the electronic device. | 10-01-2015 |
Usman Khan, London GB
Patent application number | Description | Published |
---|---|---|
20120221453 | INTELLIGENT ORDER MATCHING PLATFORM FOR ANONYMOUSLY NEGOTIATING AND TRADING FINANCIAL INSTRUMENTS - This software enables a financial institution acting as a clearing agent to offer a liquidity pool where their clients can anonymously submit orders for a financial instrument. Many financial markets suffer from reduced liquidity, the causes for which include: 1) fragmentation across multiple markets, 2) fragmentation across a large instrument universe and 3) attempting to trade an illiquid instrument. The software has been developed to uniquely improve available liquidity using crossing algorithms that intelligently identify orders for similar instruments as relevant execution opportunities, and applies a quantitative scoring of their propensity to trade on which clients can anonymously negotiate and execute. As crossing algorithms are not constrained by the conventional restriction that orders must be for identical instruments, the system is able to increase liquidity by identifying execution opportunities that existing markets cannot, while employing an anonymous negotiation process that minimizes information leakage to mitigate disruption to market prices. | 08-30-2012 |